BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 16651418)

  • 1. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of miR-489 derails mammary hierarchy structure and inhibits HER2/neu-induced tumorigenesis.
    Patel Y; Soni M; Awgulewitsch A; Kern MJ; Liu S; Shah N; Singh UP; Chen H
    Oncogene; 2019 Jan; 38(3):445-453. PubMed ID: 30104710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ErbB2/Neu-induced, cyclin D1-dependent transformation is accelerated in p27-haploinsufficient mammary epithelial cells but impaired in p27-null cells.
    Muraoka RS; Lenferink AE; Law B; Hamilton E; Brantley DM; Roebuck LR; Arteaga CL
    Mol Cell Biol; 2002 Apr; 22(7):2204-19. PubMed ID: 11884607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement for both Shc and phosphatidylinositol 3' kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis.
    Webster MA; Hutchinson JN; Rauh MJ; Muthuswamy SK; Anton M; Tortorice CG; Cardiff RD; Graham FL; Hassell JA; Muller WJ
    Mol Cell Biol; 1998 Apr; 18(4):2344-59. PubMed ID: 9528804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hunk is required for HER2/neu-induced mammary tumorigenesis.
    Yeh ES; Yang TW; Jung JJ; Gardner HP; Cardiff RD; Chodosh LA
    J Clin Invest; 2011 Mar; 121(3):866-79. PubMed ID: 21393859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammary glands exhibit molecular laterality and undergo left-right asymmetric ductal epithelial growth in MMTV-cNeu mice.
    Robichaux JP; Hallett RM; Fuseler JW; Hassell JA; Ramsdell AF
    Oncogene; 2015 Apr; 34(15):2003-10. PubMed ID: 24909172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer.
    Menezes ME; Shen XN; Das SK; Emdad L; Guo C; Yuan F; Li YJ; Archer MC; Zacksenhaus E; Windle JJ; Subler MA; Ben-David Y; Sarkar D; Wang XY; Fisher PB
    Oncotarget; 2015 Nov; 6(35):36928-42. PubMed ID: 26474456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncanonical TGF-β signaling during mammary tumorigenesis.
    Parvani JG; Taylor MA; Schiemann WP
    J Mammary Gland Biol Neoplasia; 2011 Jun; 16(2):127-46. PubMed ID: 21448580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer.
    Rowson-Hodel AR; Wald JH; Hatakeyama J; O'Neal WK; Stonebraker JR; VanderVorst K; Saldana MJ; Borowsky AD; Sweeney C; Carraway KL
    Oncogene; 2018 Jan; 37(2):197-207. PubMed ID: 28892049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with the extracellular domain of p185neu prevents mammary tumor development in neu transgenic mice.
    Esserman LJ; Lopez T; Montes R; Bald LN; Fendly BM; Campbell MJ
    Cancer Immunol Immunother; 1999 Feb; 47(6):337-42. PubMed ID: 10203064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buformin inhibits the stemness of erbB-2-overexpressing breast cancer cells and premalignant mammary tissues of MMTV-erbB-2 transgenic mice.
    Parris AB; Zhao Q; Howard EW; Zhao M; Ma Z; Yang X
    J Exp Clin Cancer Res; 2017 Feb; 36(1):28. PubMed ID: 28193239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologic progression of mammary carcinomas in a C3(1)/SV40 T/t-antigen transgenic rat model of human triple-negative and Her2-positive breast cancer.
    Hoenerhoff MJ; Shibata MA; Bode A; Green JE
    Transgenic Res; 2011 Apr; 20(2):247-59. PubMed ID: 20549348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated expression of wildtype RhoC promotes ErbB2- and Pik3ca-induced mammary tumor formation.
    Raghuram N; Temel EI; Kawamata T; Kozma KJ; Loch AJ; Wang W; Adams JR; Muller WJ; Egan SE
    Breast Cancer Res; 2024 May; 26(1):86. PubMed ID: 38807216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu.
    Fry EA; Taneja P; Inoue K
    Int J Cancer; 2017 Feb; 140(3):495-503. PubMed ID: 27553713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The normal mammary microenvironment suppresses the tumorigenic phenotype of mouse mammary tumor virus-neu-transformed mammary tumor cells.
    Booth BW; Boulanger CA; Anderson LH; Smith GH
    Oncogene; 2011 Feb; 30(6):679-89. PubMed ID: 20890308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ErbB2 is required for ductal morphogenesis of the mammary gland.
    Jackson-Fisher AJ; Bellinger G; Ramabhadran R; Morris JK; Lee KF; Stern DF
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17138-43. PubMed ID: 15569931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin regulates cyclin D1 in luminal epithelial cells of mouse MMTV-Wnt-1 mammary tumors.
    Zheng Q; Hursting SD; Reizes O
    J Cancer Res Clin Oncol; 2012 Sep; 138(9):1607-12. PubMed ID: 22692856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonally up-regulated neu-associated kinase: A novel target for breast cancer progression.
    Zambrano JN; Neely BA; Yeh ES
    Pharmacol Res; 2017 May; 119():188-194. PubMed ID: 28189783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A context-specific role for retinoblastoma protein-dependent negative growth control in suppressing mammary tumorigenesis.
    Francis SM; Chakrabarti S; Dick FA
    PLoS One; 2011 Feb; 6(2):e16434. PubMed ID: 21364977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new role of SNAI2 in postlactational involution of the mammary gland links it to luminal breast cancer development.
    Castillo-Lluva S; Hontecillas-Prieto L; Blanco-Gómez A; Del Mar Sáez-Freire M; García-Cenador B; García-Criado J; Pérez-Andrés M; Orfao A; Cañamero M; Mao JH; Gridley T; Castellanos-Martín A; Pérez-Losada J
    Oncogene; 2015 Sep; 34(36):4777-90. PubMed ID: 26096931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.